<DOC>
	<DOCNO>NCT01923389</DOCNO>
	<brief_summary>This trial obese subject study safety , tolerability , pharmacokinetics pharmacodynamics multiple dos PF-05231023 .</brief_summary>
	<brief_title>Multiple Dose Study Of PF-05231023 In Obese Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female subject nonchildbearing potential age 21 70 . Subjects BMI 30 45.4 kg/m2 total body weight &gt; 110 lb . Recent ( 6 month ) unstable concurrent disease . History allergic disease drug allergy . Any condition affect food consumption absorption .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>T2DM</keyword>
	<keyword>obesity</keyword>
	<keyword>safety</keyword>
	<keyword>multiple dose</keyword>
	<keyword>intravenous</keyword>
</DOC>